In a similar study, apoptosis is potently and synergistically triggered in FLT3‐ITD AML cell lines and primary patient samples when the FLT3 inhibitors gilteritinib or midostaurin are combined with the Bcl‐2 inhibitor venetoclax. Here, FLT3 is linked to acute myeloid leukemia.